Eikon Therapeutics Inc. Common Stock

EIKN | NASDAQ

$5.31

-$0.04 (-0.75%)

At close: Oct 30, 2026, 4:00 PM ET

$5.20

-$0.11 (-2.07%)

Pre-market: Nov 2, 2026, 6:37 AM ET

TTM Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025
Net Income	-322.16M	-233.75M	-150.79M	-71.14M
Depreciation & Amortization	21.54M	16.52M	11.4M	6.3M
Stock-Based Compensation	7.85M	7.85M	7.85M	3.99M
Other Working Capital	30.35M	16.28M	35.51M	2.35M
Other Non-Cash Items	3.76M	-100K	-2.05M	-1.4M
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	32.99M	18.42M	32.33M	2.71M
Operating Cash Flow	-256.02M	-191.06M	-101.26M	-59.54M
Capital Expenditures	-3.18M	-2.93M	-2.67M	-2.6M
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	-509.47M	-429.65M	-122.7M	-68.72M
Sales Maturities Of Investments	424.25M	297.75M	193.75M	99M
Other Investing Acitivies	n/a	n/a	n/a	n/a
Investing Cash Flow	-88.4M	-134.83M	68.39M	27.68M
Debt Repayment	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a
Financial Cash Flow	350.63M	350.61M	1.3M	211K
Net Cash Flow	6.14M	24.68M	-31.57M	-31.65M
Free Cash Flow	-259.2M	-193.99M	-103.93M	-62.14M
Adj. Free Cash Flow	-267.05M	-201.84M	-111.78M	-66.13M
Maintenance CapEx	-3.18M	n/a	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a
Owner Earnings	-259.2M	n/a	n/a	n/a